|
⚲
|
| NAPO Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001188290 |
| Sale | 2009-05-12 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6506161900 |
| Address | 250 E Grand Avenue South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Steven King | |
| Charles Thompson | |
| Lisa Conte | |
| Sir William Young | |
| Jack van Hulst | |
| Pravin Chaturvedi | |
| Thomas van Dyck | |
| Gregory Stock |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
HAI Technologies Inc
✚
|
0.0 | |
|
Haize Labs Jun 2024 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Haize Labs SPV Jun 2024 a Series of CGF2021 LLC
✚
|
0.0 | |
|
Torres Isaac
✚
|
0.0 | |
|
OK-1108 Fund I AL, a series of FDVC, LP
✚
|
0.0 | |
|
OK-1108 Fund I, a series of FDVC, LP
✚
|
0.0 | |
|
Okabe Kensuke
✚
|
0.0 | |
|
Okel Thomas
✚
|
0.0 | |
|
Halperin Wernli Miri
✚
|
0.0 | |
|
Guth Robert E
✚
|
0.0 |